Skip to Content
Merck
  • Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products.

Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products.

Yao xue xue bao = Acta pharmaceutica Sinica (2011-02-26)
Xiu-mei Dai, Ning An, Jian-min Wu, Hui-yi Li, Qi-ming Zhang
ABSTRACT

An HPLC-UV method has been developed for the determination of valibose, miglitol, voglibose and acarbose, the four anti-diabetic drugs. The separation was accomplished successfully by using reversed phase chromatography (Prevail carbohydrate column, 250 mm x 4.6 mm, 5 microm) with a gradient acetonitrile-phosphate buffer solution (pH 8.0) at a wavelength of 210 nm. Furthermore, the method of a high-performance liquid chromatography coupled with ESI-MS in positive ionization mode has been established. These two methods were successfully applied to the assay and qualitative detection of four alpha-glucosidase inhibitors in the potential counterfeit anti-diabetic drugs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Miglitol
Sigma-Aldrich
Voglibose, ≥97.0% (TLC)